AQST
Price
$2.39
Change
+$0.14 (+6.22%)
Updated
Dec 1, 6:59 PM EST
94 days until earnings call
EVO
Price
$9.96
Change
-$0.05 (-0.50%)
Updated
Dec 1, 6:59 PM EST
117 days until earnings call
Ad is loading...

Compare predictions AQST vs EVO

Header iconAQST vs EVO Comparison
Open Charts AQST vs EVOBanner chart's image
Aquestive Therapeutics
Price$2.39
Change+$0.14 (+6.22%)
Volume$577.25K
CapitalizationN/A
Evotec SE
Price$9.96
Change-$0.05 (-0.50%)
Volume$29.42K
CapitalizationN/A
View a ticker or compare two or three
AQST vs EVO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AQST vs. EVO commentary
Dec 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and EVO is a StrongSell.

COMPARISON
Comparison
Dec 03, 2023
Stock price -- (AQST: $2.39 vs. EVO: $9.96)
Brand notoriety: AQST and EVO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 377% vs. EVO: 157%
Market capitalization -- AQST: $129.53M vs. EVO: $3.53B
AQST [@Pharmaceuticals: Other] is valued at $129.53M. EVO’s [@Pharmaceuticals: Other] market capitalization is $3.53B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $82.08B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 1 FA rating(s) are green whileEVO’s FA Score has 1 green FA rating(s).

  • AQST’s FA Score: 1 green, 4 red.
  • EVO’s FA Score: 1 green, 4 red.
According to our system of comparison, AQST is a better buy in the long-term than EVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 6 TA indicator(s) are bullish while EVO’s TA Score has 6 bullish TA indicator(s).

  • AQST’s TA Score: 6 bullish, 4 bearish.
  • EVO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, EVO is a better buy in the short-term than AQST.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +12.74% price change this week, while EVO (@Pharmaceuticals: Other) price change was -2.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.45%. For the same industry, the average monthly price growth was +39.13%, and the average quarterly price growth was -6.49%.

Reported Earning Dates

AQST is expected to report earnings on Mar 05, 2024.

EVO is expected to report earnings on Mar 28, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+3.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for AQST with price predictions.
OPEN
A.I.dvisor published
a Summary for EVO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EVO($3.53B) has a higher market cap than AQST($130M). AQST YTD gains are higher at: 164.937 vs. EVO (23.115). AQST has higher annual earnings (EBITDA): -4.76M vs. EVO (-63.26M). EVO has more cash in the bank: 619M vs. AQST (24.9M). AQST has less debt than EVO: AQST (45M) vs EVO (589M). EVO has higher revenues than AQST: EVO (821M) vs AQST (48.1M).
AQSTEVOAQST / EVO
Capitalization130M3.53B4%
EBITDA-4.76M-63.26M8%
Gain YTD164.93723.115714%
P/E RatioN/A476.19-
Revenue48.1M821M6%
Total Cash24.9M619M4%
Total Debt45M589M8%
FUNDAMENTALS RATINGS
EVO: Fundamental Ratings
EVO
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AQSTEVO
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLAU26.850.54
+2.07%
Franklin FTSE Australia ETF
HACK57.490.73
+1.29%
ETFMG Prime Cyber Security ETF
GVAL20.950.26
+1.26%
Cambria Global Value ETF
DTH37.740.35
+0.94%
WisdomTree International High Div ETF
SANE22.960.11
+0.46%
Subversive Mental Health ETF

AQST and

Correlation & Price change

A.I.dvisor tells us that AQST and HROW have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQST and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+6.22%
HROW - AQST
28%
Poorly correlated
+0.98%
ACET - AQST
26%
Poorly correlated
+3.39%
CPHI - AQST
26%
Poorly correlated
+10.43%
SNDL - AQST
24%
Poorly correlated
+4.90%
TARO - AQST
23%
Poorly correlated
+2.50%
More